Search

Author/Creator Bottomley, A

1. 1278PHealth-related quality-of-life results for pembrolizumab versus placebo after complete resection of high-risk stage III melanoma from the EORTC 1325-MG/Keynote 054 trial: An international randomized double-blind phase III trial. (23rd October 2018)

Authors:
Coens, C; Bottomley, A; Blank, C U; Mandala, M; Long, G V; Atkinson, V G; Dalle, S; Haydon, A; Lichinitser, M; Khattak, A; Carlino, M S; Sandhu, S K; Larkin, J; Puig Sarda, S; Ascierto, P A; Schadendorf, D; Ibrahim, N; Suciu, S; Robert, C; Eggermont, A M M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 193OAn international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45. (23rd October 2018)

Authors:
Bjelic-Radisic, V; Bottomley, A; Cardoso, F; Cameron, D; Brain, E; Kuljanic, K; de Costa, R A; Conroy, T; Inwald, E; Serpentini, S; Pinto, M; Weis, J; Morag, O; Guro Lindviksmoen Astrup, G; Tomaszweksi, K; Pogoda, K; Sinai, P; Sprangers, M A G; Aaronson, N; Greimel, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making. (6th September 2019)

Authors:
Coomans, M; Taphoorn, M J B; Aaronson, N; Baumert, B G; van den Bent, M; Bottomley, A; Brandes, A A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Stupp, R; Talacchi, A; Weller, M; Wick, W; Reijneveld, J C; Dirven, L
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 3
Page Start:
iii14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM). (6th September 2019)

Authors:
Coomans, M; Dirven, L; Bottomley, A; van den Bent, M; Sloan, J; Stupp, R; Weller, M; Reijneveld, J C; Taphoorn, M; Aaronson, N; Baumert, B G; Brandes, A A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Talacchi, A
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 3
Page Start:
iii14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. PL03.4.A Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period. (9th September 2021)

Authors:
Coomans, M; Dirven, L; Aaronson, N; Baumert, B; van den Bent, M; Bottomley, A; Brandes, A; Chinot, O; Coens, C; Gorlia, T; Herrlinger, U; Keime-Guibert, F; Malmström, A; Martinelli, F; Stupp, R; Talacchi, A; Wick, W; Reijneveld, J; Taphoorn, M
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 2(2021)
Page Start:
ii2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗